Rare diseases
Investigational molecules
Locations
Safety and Pharmacokinetics of MIB2 (StaphAcute) in Healthy Volunteers and Patients with Staphylococcus aureus Bacteremia
GermanyA Randomized Double‑Blind Study of Pharmacokinetic Similarity of AVT32‑DRL_PB and Pembrolizumab in Patients with Resected Stage IIB‑C‑III Melanoma
RomaniaPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
FinlandA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
AustriaLong‑Term Study of Acoramidis on Heart Function and Amyloid Burden in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR‑CM)
DenmarkSafety and Tolerability of AZD4956 Alone or with Saruparib in Adults with Advanced Metastatic Solid Tumors (Phase I/IIa)
SpainPhase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)
DenmarkA Phase II Study of Cadonilimab Plus Lenvatinib Versus Lenvatinib in Advanced Hepatocellular Carcinoma After Atezolizumab/Bevacizumab Progression
FranceA study of SAR448851 with FLORQUINITAU (18F) to assess safety and effectiveness in early Alzheimer’s disease
GermanyPhase 1/2 Study Evaluating Safety and Activity of GSK5926371 in Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
FinlandEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
CzechiaSafety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
